Literature DB >> 32705476

Changes in Mortality in Top 10 Causes of Death from 2011 to 2018.

Jamal S Rana1,2,3, Sadiya S Khan4,5, Donald M Lloyd-Jones4,5, Stephen Sidney6.   

Abstract

Entities:  

Year:  2020        PMID: 32705476      PMCID: PMC7377530          DOI: 10.1007/s11606-020-06070-z

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.

INTRODUCTION

Trends in mortality rates due to leading causes of death reflect the medical, psychosocial, and economic well-being of a society, and a historical snapshot of such trends can help inform policies of the future. Therefore, we examined changes in the number of deaths and age-adjusted mortality rates (AAMR) attributed to the top 10 causes of death between 2011 and 2018, the last year we have data available from the Centers for Disease Control and Prevention. We chose 2011 as the start date because of earlier work showing a transition in 2011 in 2 of the top 10 causes of death (heart disease and stroke) from a long-term decline to increasing numbers of deaths since then.[1]

METHODS

The Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research (CDC WONDER) dataset was used to identify national changes in the number of deaths and AAMR due to the top 10 underlying causes of death from January 1, 2011, to December 31, 2018.[2] The population projection was obtained from U.S. Census data.[3]

RESULTS

As of 2018, the top 3 causes of death were heart disease, cancer, and accidents (Table 1). The largest percentage decline for AAMR occurred for cancer deaths (− 11.8%), and the greatest increase in AAMR occurred for deaths due to Alzheimer disease (+ 23.5%). AAMR for influenza and pneumonia (− 5.1%) and chronic lower respiratory diseases (− 6.6%) declined. Increases in AAMR due to accidental deaths (+ 22.8%) and intentional self-harm (suicide) (+ 15.4%) were observed.
Table 1

Changes in Mortality Attributed to the Top 10 Causes of Death in the USA, 2011–2018

Total deathsAge-adjusted mortality rate (per 100,000 population)
20112018Absolute change, NPercent change (%)20112018Absolute change in AAMRPercent change in AAMR (%)
1. Heart disease (I00–I09, I11, I13, I20–I51)596,577655,381+ 58,804+ 9.9173.7163.6− 10.1− 5.8
2. Cancer (C00–C97)576,691599,274+ 22,583+ 3.9169.0149.1− 19.9− 11.8
3. Accidents (V01–X59, Y85–Y86)126,438167,127+ 40,689+ 32.239.148.0+ 8.9+ 22.8
4. Chronic lower respiratory diseases (J40–J47)142,943159,486+ 16,543+ 11.642.539.7− 2.8− 6.6
5. Cerebrovascular diseases (I60–I69)128,932147,810+ 18,878+ 14.637.937.1− 0.8− 2.1
6. Alzheimer disease (G30)84,974122,019+ 37,04543.624.730.5+ 5.8+ 23.5
7. Diabetes mellitus (E10–E14)73,83184,946+ 11,115+ 15.121.621.4− 0.2− 0.9
8. Influenza and pneumonia (J09–J18)53,82659,120+ 5294+ 9.815.714.9− 0.8− 5.1
9. Nephritis, nephrotic syndrome and nephrosis (N00–N07, N17–N19, N25–27)45,59151,386+5795+ 12.713.412.9− 0.5− 3.7
10. Intentional self-harm (suicide) (U03, X60–X84, Y87.0)39,51848,344+8826+ 22.312.314.2+ 1.9+ 15.4
Changes in Mortality Attributed to the Top 10 Causes of Death in the USA, 2011–2018 Even though the AAMR declined for 7 of the 10 top causes of death, the number of deaths increased for all 10 of the leading causes. This is because the older (age ≥ 65 years) age group grew at a much more rapid rate than that of the younger (age < 65 years) (26.7% vs. 1.7%), while 70% or more of the deaths from 8 of these causes were concentrated in older (age ≥ 65 years) adults (Table 2).
Table 2

Number of Deaths, Age ≥ 65 Years, and Percentage of All Deaths, 2018

Number of deaths% of all deaths
Heart disease526,50980.3
Cancer431,10271.9
Accidents57,21334.2
Chronic lower respiratory disease135,56085.0
Cerebrovascular disease127,24486.1
Alzheimer’s disease120,65898.9
Diabetes mellitus60,18270.8
Influenza and pneumonia48,88882.7
Nephritis, nephrotic syndrome, and nephrosis42,23282.2
Intentional self-harm (suicide)914718.9
Number of Deaths, Age ≥ 65 Years, and Percentage of All Deaths, 2018

DISCUSSION

Important patterns of change in AAMR in the past decade have been previously noted, from stalling of the decline in mortality due to heart disease[1] to decrease in life expectancy attributed to drug overdoses and suicides among young and middle-aged adults.[4] While interventions to prevent and treat coronary heart disease (CHD) have been successful, with age-adjusted mortality rate decrease 14.9% in last decade, the worrisome plateau in the decline in heart disease mortality seems to be driven by an increase in mortality for heart failure (20.7%), with majority of deaths due to heart disease happening in the increasing aging population.[5] The largest percent decline during this time period of the study was noted for cancers. According to a recent report, this progress is driven by long-term declines in death rates for the 4 leading cancers, namely lung, colorectal, breast, and prostate cancers. That report also noted that over 2008–2017, reductions slowed for female breast and colorectal cancers and stopped for prostate cancer; in contrast, declines accelerated for lung cancer, which remains the biggest contributor of mortality among cancers.[6] It remains to be seen what the final death toll will be due to COVID-19 in 2020. With more than 90,000 deaths by May, it has already surpassed the number of deaths attributed to all but the 6 of the leading causes of deaths in 2018 including influenza and pneumonia, the 8th highest cause of mortality in 2018. Due to the direct and myriad of indirect consequences of this pandemic, mortality rankings due to top 10 causes noted in the current report may look very different in 2020. As noted, almost three-quarters of the deaths from 8 of these causes were concentrated in older (age ≥ 65 years) adults. Further, the ≥ 65 years population is projected to increase by 39% from 52.4 million in 2018 to 73.1 million in 2030[3] so that the number of deaths from most of the 10 leading causes can be expected to increase unless more effective preventive and therapeutic interventions can be implemented. With approximately 600,000 and more annual deaths due to each, cancer and heart disease, they are likely to remain the top 2 causes respectively, and a sobering reminder that long-term societal challenge of these non-communicable diseases remains.
  23 in total

Review 1.  Regenerating dynamic organs using biomimetic patches.

Authors:  Parth Chansoria; Emma L Etter; Juliane Nguyen
Journal:  Trends Biotechnol       Date:  2021-08-16       Impact factor: 19.536

Review 2.  Could "cellular exercise" be the missing ingredient in a healthy life? Diets, caloric restriction, and exercise-induced hormesis.

Authors:  Iv John L Pinches; Yiuing L Pinches; John O Johnson; Natasha C Haddad; Myriam G Boueri; Luc M Oke; Georges E Haddad
Journal:  Nutrition       Date:  2022-02-07       Impact factor: 4.893

3.  Excess all-cause mortality and COVID-19 reported fatality in Iran (April 2013-September 2021): age and sex disaggregated time series analysis.

Authors:  Seyed Amir Ahmad Safavi-Naini; Yeganeh Farsi; Walid Q Alali; Ali Solhpour; Mohamad Amin Pourhoseingholi
Journal:  BMC Res Notes       Date:  2022-04-05

4.  Multimerization of the GATA4 transcription factor regulates transcriptional activity and cardiomyocyte hypertrophic response.

Authors:  Satoshi Shimizu; Yoichi Sunagawa; Naruto Hajika; Natsumi Yorimitsu; Yasufumi Katanasaka; Masafumi Funamoto; Yusuke Miyazaki; Nurmila Sari; Kana Shimizu; Koji Hasegawa; Tatsuya Morimoto
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

5.  Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial.

Authors:  M M Gonzales; V R Garbarino; E Marques Zilli; R C Petersen; J L Kirkland; T Tchkonia; N Musi; S Seshadri; S Craft; M E Orr
Journal:  J Prev Alzheimers Dis       Date:  2022

6.  Validation of a Lab-on-Chip Assay for Measuring Sorafenib Effectiveness on HCC Cell Proliferation.

Authors:  Emanuele Piccinno; Anna Grazia Monteduro; Francesco Dituri; Silvia Rizzato; Gianluigi Giannelli; Giuseppe Maruccio
Journal:  Int J Mol Sci       Date:  2021-12-03       Impact factor: 5.923

Review 7.  Effectiveness of Pre-Hospital Tourniquet in Emergency Patients with Major Trauma and Uncontrolled Haemorrhage: A Systematic Review and Meta-Analysis.

Authors:  Roberto Latina; Laura Iacorossi; Alice Josephine Fauci; Annalisa Biffi; Greta Castellini; Daniela Coclite; Daniela D'Angelo; Silvia Gianola; Veronica Mari; Antonello Napoletano; Gloria Porcu; Matteo Ruggeri; Primiano Iannone; Osvaldo Chiara
Journal:  Int J Environ Res Public Health       Date:  2021-12-06       Impact factor: 3.390

8.  Classification of moving coronary calcified plaques based on motion artifacts using convolutional neural networks: a robotic simulating study on influential factors.

Authors:  Magdalena Dobrolińska; Niels van der Werf; Marcel Greuter; Beibei Jiang; Riemer Slart; Xueqian Xie
Journal:  BMC Med Imaging       Date:  2021-10-19       Impact factor: 1.930

9.  The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms.

Authors:  Chiara Baldini; Francesca Romana Moriconi; Sara Galimberti; Peter Libby; Raffaele De Caterina
Journal:  Eur Heart J       Date:  2021-11-07       Impact factor: 35.855

10.  On the Sensitivity Analysis of Porous Finite Element Models for Cerebral Perfusion Estimation.

Authors:  T I Józsa; R M Padmos; W K El-Bouri; A G Hoekstra; S J Payne
Journal:  Ann Biomed Eng       Date:  2021-06-21       Impact factor: 3.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.